These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 33245019)
1. What are the mechanisms of action of the different contraceptive methods to reduce the risk of ovarian cancer? Sánchez-Borrego R; Sánchez-Prieto M Eur J Contracept Reprod Health Care; 2021 Feb; 26(1):79-84. PubMed ID: 33245019 [TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery. Venkatesh KK; Clark LH; Stamilio DM Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036 [TBL] [Abstract][Full Text] [Related]
3. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage. Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477 [TBL] [Abstract][Full Text] [Related]
4. The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction. Subramaniam A; Einerson BD; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK Gynecol Oncol; 2019 Jan; 152(1):127-132. PubMed ID: 30477808 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic salpingectomy for the prevention of ovarian cancer: Who should we target? Kotsopoulos J; Narod SA Int J Cancer; 2020 Sep; 147(5):1245-1251. PubMed ID: 32037528 [TBL] [Abstract][Full Text] [Related]
6. The Role of Opportunistic Bilateral Salpingectomy vs Tubal Occlusion or Ligation for Ovarian Cancer Prophylaxis. Ely LK; Truong M J Minim Invasive Gynecol; 2017; 24(3):371-378. PubMed ID: 28087480 [TBL] [Abstract][Full Text] [Related]
7. Salpingectomy and Ovarian Cancer Prevention. Harris AL Nurs Womens Health; 2015 Dec-2016 Jan; 19(6):543-9. PubMed ID: 26682662 [TBL] [Abstract][Full Text] [Related]
8. Female tubal sterilization: the time has come to routinely consider removal. Creinin MD; Zite N Obstet Gynecol; 2014 Sep; 124(3):596-599. PubMed ID: 25162262 [TBL] [Abstract][Full Text] [Related]
9. Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer. Walker JL; Powell CB; Chen LM; Carter J; Bae Jump VL; Parker LP; Borowsky ME; Gibb RK Cancer; 2015 Jul; 121(13):2108-20. PubMed ID: 25820366 [TBL] [Abstract][Full Text] [Related]
10. Non-hormonal interruption of incessant ovulation as a potential approach for ovarian cancer prevention. Fathalla MF Int J Gynaecol Obstet; 2016 Mar; 132(3):356-8. PubMed ID: 26876699 [TBL] [Abstract][Full Text] [Related]
12. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada. Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159 [TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer risk after salpingectomy: a nationwide population-based study. Falconer H; Yin L; Grönberg H; Altman D J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25628372 [TBL] [Abstract][Full Text] [Related]
14. Barriers to salpingectomy for permanent contraception: A qualitative study with obstetricians and gynaecologists. Obermair HM; Muir G; Gard GB Aust N Z J Obstet Gynaecol; 2021 Dec; 61(6):973-977. PubMed ID: 34554566 [TBL] [Abstract][Full Text] [Related]
15. Salpingectomie bilatérale aux fins de contraception permanente : série de cas et facteurs limitant le changement de pratique. Ruel-Laliberté J; Binette A; Bertrand A J Obstet Gynaecol Can; 2020 Aug; 42(8):948-952. PubMed ID: 32345552 [TBL] [Abstract][Full Text] [Related]
16. Primary prevention of ovarian cancer: a patient decision aid for opportunistic salpingectomy. van Lieshout LAM; Gelderblom ME; de Hullu JA; The R; van Ginkel AA; Oerlemans AJM; Smeets KMWH; Schreurs MPH; Piek JMJ; Hermens RPMG Am J Obstet Gynecol; 2022 Feb; 226(2):234.e1-234.e14. PubMed ID: 34536392 [TBL] [Abstract][Full Text] [Related]
17. Fallopian tube tumorigenesis and clinical implications for ovarian cancer risk-reduction. Gockley AA; Elias KM Cancer Treat Rev; 2018 Sep; 69():66-71. PubMed ID: 29909222 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of opportunistic salpingectomy for ovarian cancer prevention. Dilley SE; Havrilesky LJ; Bakkum-Gamez J; Cohn DE; Michael Straughn J; Caughey AB; Rodriguez MI Gynecol Oncol; 2017 Aug; 146(2):373-379. PubMed ID: 28577884 [TBL] [Abstract][Full Text] [Related]
19. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy. Ayres C; Ratnayake G; McNally O; Quinn M Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030 [TBL] [Abstract][Full Text] [Related]
20. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study. Madsen C; Baandrup L; Dehlendorff C; Kjaer SK Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]